Ignite Creation Date:
2024-05-06 @ 10:48 AM
Last Modification Date:
2024-10-26 @ 12:36 PM
Study NCT ID:
NCT03358004
Status:
TERMINATED
Last Update Posted:
2018-10-05
First Post:
2017-11-13
Brief Title:
the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients TNBC as Maintenance Therapy After First Line Treatment
Sponsor:
Mario Negri Institute for Pharmacological Research
Organization:
Mario Negri Institute for Pharmacological Research
Organization Data
Organization:
Mario Negri Institute for Pharmacological Research
Class:
OTHER
Study ID:
IRFMN-BRC-6992
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mario Negri Institute for Pharmacological Research
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None